Skip to main content

Latest News

Accutar Biotech announces closing of latest financing round

Apr 18,  2021

Accutar Biotech has recently completed a new round of funding from Yunfeng Capital, Coatue, and 3W Healthcare Fund, in addition to the previous investments from ZhenFund, IDG Capital, YITU Technology, Primavera Capital Group, CDH Investments, and other institutional investors. Accumulatively, Accutar Biotech has now raised over US$100 million to support the advancement of the world-leading artificial intelligence (AI)-empowered platform and the expansion of our...

Read More

Accutar Biotech tops the ongoing IDG-DREAM Drug-Kinase Binding Prediction Challenge

Dec 19,  2018

Based on round 1 submission results, the Accutar Biotech team ranked number 1 of over 300 participants in the IDG-DREAM Drug-Kinase Binding Prediction Challenge.

Read More

Accutar Biotech presents at Amgen’s artificial intelligence conference in Boston

Dec 07,  2018

Accutar Biotech CEO, Dr. Jie Fan, was invited to present at Amgen’s artificial intelligence conference.

Read More

Accutar Biotech presents at the 2018 World Artificial Intelligence Conference in Shanghai

Sep 22,  2018
Dr. Jie Fan presents at the ‘Vision for the AI Future – Where Intelligence and Wisdom Meet’ 2018 World Artificial Intelligence Conference in Shanghai.

Read More

Dr. Jie Fan presents to the Artificial Intelligence in Drug Discovery panel at the 2018 Sino-American Pharmaceutical Professionals Association – Greater Philadelphia (SAPA-GP) Conference

Jul 08,  2018
Read More